Benitez, Pacita M.
HRN: 26-96-38 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/15/2025
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
04/15/2025
04/22/2025
IV
1.5 Grams
Q6H
Psoas Abcess
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes